Clement Y. Chow, PhD Linkedin Twitter Facebook Google The genetic variation found in natural populations is a rich unbiased resource for identifying novel elements of biological pathways. Variation is often exploited to study adaptive traits but remains under-utilized in the study of disease modifiers and pathways. Understanding how a particular pathway varies within a population […]
Alan Renton, PhD Google Dr. Renton’s expertise is the generation and analysis of genomic and functional data to identify and characterize neurodegenerative disease genes. His interests have encompassed a range of disorders, specifically Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Parkinson’s disease (PD), and progressive supranuclear palsy (PSP). His ongoing and future
Susanne Van Veluw, PhD Linkedin Twitter Google Dr. Van Veluw is interested in the vascular contributions to dementia, and have a strong background in neuroimaging and neuropathology. Her current research focuses on one of the most common age-related cerebral small vessel diseases; cerebral amyloid angiopathy (CAA). She use both in vivo clinical MRI as well
Jason Ulrich, PhD Linkedin Dr. Ulrich is an Assistant Professor in Neurology at Washington University in St. Louis. He began working in the field of Alzheimer’s disease (AD) after obtaining his PhD in Pharmacology at the University of Iowa. During his post-doctoral training with David Holtzman at Washington University he became interested in the role
Fabienne E. Poulain, PhD Google Dr. Poulain is originally from France and obtained her PhD from the University Paris 6-Pierre et Marie Curie, studying the roles of microtubule-regulating proteins stathmin in neuronal morphogenesis. She became convinced that observing axon growth directly in the embryo in vivo would provide invaluable insights on how axons integrate different signals from the
Geraldine Kress, PhD Linkedin Google Dr. Kress’ research interests focus on understanding interactions between cognitive function and the circadian system during the aging process and Alzheimer’s disease (AD) progression in order to identify pathophysiology changes, mechanisms, and possible strategies to ameliorate disease progression. A growing body of evidence suggests that disruptions to the circadian system
Sylvia Kang, PhD Linkedin One of my major career goals is to understand the interplay between immunity and neurobiology. My hypothesis is that factors that shape peripheral immunity and microglial reactivity impact neuroinflammation and long-term cognitive impairment as occurs in Alzheimer’s disease (AD). This is especially important since many AD genes are known or suggested
Katherine A. Gifford PsyD Linkedin Google Dr. Katherine Gifford is an Assistant Professor in the Department of Neurology at Vanderbilt University. She obtained her bachelor’s degree in psychology at Skidmore College in Saratoga Springs, NY and her doctoral degree in clinical psychology from the Florida Institute of Technology in Melbourne, FL. She completed her pre-doctoral
Andrew Arrant, PhD Linkedin Google Dr. Arrant graduated with a B.S. in Toxicology from the University of Louisiana at Monroe in 2007. He then entered the Integrated Toxicology and Environmental Health Program at Duke University, and in 2012 earned a PhD in Pharmacology in the laboratory of Dr. Cynthia Kuhn. In 2013, Dr. Arrant joined the
A list of all CCAD alumni NIH Grants for 2020 and part of 2019. This is part of our quarterly series newsletter “CCAD Connections.”
2020 NIH Awards to CCAD Alumni Read More »
